Acesso livre
Acesso livre

Geriatria

Um painel da FDA afirma que somente americanos de alto risco e os maiores de 65 anos deveriam tomar as doses de reforço contra Covid.

20 Set, 2021 | 13:56h

An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters – NPR

Ver também:

FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans – STAT

5 reasons why FDA advisers did not recommend Covid-19 booster shots for everyone – CNN

Top doctors say not so fast to Biden’s boosters-for-all plan – Associated Press

Conteúdos relacionados:

An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.

Third shot: UK to offer COVID booster jabs to over 50s.

COVID-19 vaccine efficacy does not support boosters for general population, review concludes.

COVID vaccine effects wane over time but still prevent death and severe illness.

What’s the evidence for COVID-19 booster shots?

WHO appeals for countries to postpone COVID-19 vaccine boosters until 2022 to prioritize vaccinating the most at-risk people around the world who are yet to receive their first dose.

AstraZeneca bosses warn against rush for boosters – “giving the most vulnerable, who may not have built up a full immune response from the first two, a third, top-up dose is “sensible”. But any decision to give a third, booster jab “to large swathes of the population”, to extend their protection from the first two, must be based on clinical data”.


Diretriz AAN | Considerações éticas sobre o diagnóstico e o cuidado da demência.

17 Set, 2021 | 12:59h

Ethical Considerations in Dementia Diagnosis and Care: AAN Position Statement – Neurology


Estudo observacional em Israel sugere proteção adicional da terceira dose da vacina da Pfizer em pessoas com mais de 60 anos de idade.

17 Set, 2021 | 12:42h

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine


Ponto de vista | Tratamento de multimorbidade em pacientes idosos: já estamos prontos para a medicina de precisão na terapia intensiva?

14 Set, 2021 | 14:14h

The management of multi-morbidity in elderly patients: Ready yet for precision medicine in intensive care? – Critical Care


Estudo mostra que a decisão de “não ressuscitar” é registrada somente em 1 a cada 5 pacientes idosos, muito doentes e hospitalizados.

14 Set, 2021 | 14:08h

‘Do not resuscitate’ decision recorded for only 1 in 5 very sick older patients, study finds – News Medical

Estudo original: Do not attempt cardiopulmonary resuscitation (DNACPR) decisions for older medical inpatients: a cohort study – BMJ Supportive & Palliative Care


Risco de Covid-19 severa em indivíduos já vacinados é maior para idosos e pessoas com condições subjacentes.

12 Set, 2021 | 22:22h

Risk of severe breakthrough Covid-19 higher for seniors and people with underlying conditions – CNN

Estudo original: Hospitalisation among vaccine breakthrough COVID-19 infections – The Lancet Infectious Diseases

Comunicado de imprensa: Study examines severe breakthrough cases of COVID-19 – YaleNews

 

Comentário no Twitter

 


Pessoas com doença de Parkinson podem se beneficiar de 7 estratégias de caminhada.

12 Set, 2021 | 22:04h

Comunicado de imprensa: People with Parkinson’s may benefit from seven walking strategies – American Academy of Neurology

Estudo original: Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease – Neurology

Comentário: Compensation Strategies Benefit Parkinson Patients With Gait Impairment – HealthDay

 

Comentário no Twitter (fio – clique para saber mais)

 


Editorial | Drogas anticolinérgicas e demência: hora de transparência diante da incerteza.

12 Set, 2021 | 20:11h

Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Revisão sistemática: Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

 

Comentário no Twitter

 


Perspectiva | Repensando a adesão a medicamentos.

12 Set, 2021 | 20:08h

Rethinking Medication Adherence – Therapeutics Initiative


Alimentação via sonda para pessoas com demência grave: tomada de decisão.

7 Set, 2021 | 21:59h

Tube feeding for people with severe dementia: making decisions – Evidently Cochrane

Artigo original: Systematic review: Enteral tube feeding for people with severe dementia – “We found no evidence that tube feeding improves survival; improves quality of life; reduces pain; reduces mortality; decreases behavioural and psychological symptoms of dementia”.


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.